Supporting TLR2 and 4's involvement in potentiating inflammation, another group has shown that patients with Type 1 diabetes mellitus and microvascular complications exhibited augmented expression of TLR2, 4 and biomarkers of inflammation in their monocytes compared to patients without microvascular complications [20]. Here, TLR2 is linked to type 1 diabetes mellitus.